Vontobel Holding Ltd. Increases Holdings in Tilray Inc (NASDAQ:TLRY)

Vontobel Holding Ltd. increased its stake in Tilray Inc (NASDAQ:TLRY) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 278,199 shares of the company’s stock after buying an additional 7,362 shares during the quarter. Vontobel Holding Ltd.’s holdings in Tilray were worth $640,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Clear Street Markets LLC acquired a new stake in Tilray in the third quarter valued at approximately $25,000. Lake Street Financial LLC purchased a new position in shares of Tilray in the third quarter valued at $28,000. Great Valley Advisor Group Inc. acquired a new stake in Tilray during the 3rd quarter valued at $29,000. Stratos Wealth Advisors LLC purchased a new stake in Tilray during the 3rd quarter worth $31,000. Finally, Simplicity Solutions LLC purchased a new position in Tilray in the 3rd quarter valued at about $32,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Tilray Stock Down 0.6 %

Shares of Tilray stock opened at $1.72 on Tuesday. The business has a 50-day moving average price of $1.95 and a 200 day moving average price of $1.95. Tilray Inc has a fifty-two week low of $1.50 and a fifty-two week high of $3.40. The firm has a market cap of $1.33 billion, a P/E ratio of -3.91 and a beta of 2.36. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11.

Wall Street Analyst Weigh In

TLRY has been the topic of a number of analyst reports. Alliance Global Partners lifted their target price on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a research report on Friday, April 5th. Canaccord Genuity Group cut their target price on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Finally, CIBC decreased their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a research report on Wednesday, April 10th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.